C Théodore

Author PubWeight™ 25.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924. J Clin Oncol 2001 2.06
2 The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer 2000 1.74
3 A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992 1.71
4 Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study. Ann Oncol 2001 1.44
5 Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients. Cancer 1996 1.23
6 Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group. J Clin Oncol 2001 1.20
7 Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP). Ann Oncol 2007 1.11
8 Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse. Eur J Cancer 2001 1.06
9 The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area. Br J Cancer 2005 1.05
10 Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy. J Clin Oncol 1998 1.04
11 Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy. Ann Oncol 1997 0.95
12 Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial. Ann Oncol 2005 0.92
13 Multimodality treatment of patients with liver metastases from germ cell tumors: the role of surgery. Cancer 2001 0.90
14 Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience. Cancer 1996 0.90
15 Free hCG-beta subunit as tumour marker in urothelial cancer. Lancet 1993 0.88
16 Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy? Eur J Cancer 1998 0.87
17 Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases--a pilot study. Eur J Surg Oncol 1987 0.81
18 Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy. Ann Oncol 1993 0.79
19 Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors. Am J Clin Oncol 1997 0.78
20 Phase II study of all-trans retinoic acid administered intermittently for hormone refractory prostate cancer. J Urol 1999 0.78
21 [Mesenteric venous infarction and protein C deficiency]. Gastroenterol Clin Biol 1989 0.78
22 Association between germ cell tumours, large numbers of naevi, atypical naevi and melanoma. Melanoma Res 2001 0.77
23 [Primary mediastinal non-seminomatous germ-cell tumors: from clinics to biology]. Bull Cancer 1997 0.77
24 Cisplatin-based chemotherapy in advanced seminoma: the Institut Gustave Roussy experience. Eur J Cancer 1998 0.76
25 [Radiation-induced mucositis: a new indication of sucralfate?]. Gastroenterol Clin Biol 1987 0.75
26 Second-line M-VAC therapy in patients previously treated with the M-VAC regimen for metastatic urothelial cancer. Ann Oncol 1993 0.75
27 [Treatment of infiltrating nonmetastatic bladder cancers in elderly patients]. Prog Urol 2009 0.75
28 [Jejunal amyloidosis: diagnosis by biopsy conducted by jejunoscopy; 2 cases]. Gastroenterol Clin Biol 1981 0.75
29 [Chemotherapy in advanced transitional cell carcinoma of the urinary tract. Phase II trial of a combination of doxorubicin and cisplatin]. J Urol (Paris) 1990 0.75
30 [Adenomatous lesions of the papilla in familial adenomatous rectocolic polyposis. Value of duodenoscopy]. Gastroenterol Clin Biol 1983 0.75
31 [Liposarcoma of the spermatic cord: apropos of a case with review of the literature]. Bull Cancer 1994 0.75
32 [Skin manifestations of the Rosai-Dorfman syndrome]. Ann Dermatol Venereol 1984 0.75
33 [Adjuvant chemotherapy of infiltrating bladder cancer. A feasibility trial]. J Urol (Paris) 1985 0.75
34 [Culture of intestinal cells]. Gastroenterol Clin Biol 1979 0.75
35 [Abdominal pain caused by the passage of the current from electro- coagulation during endoscopic colonic polypectomy]. Gastroenterol Clin Biol 1984 0.75
36 [Salmonella colitis]. Gastroenterol Clin Biol 1982 0.75
37 [Digestive lymphosarcomas. Apropos of 30 cases]. Sem Hop 1983 0.75
38 [Acute respiratory failure due to Gemcitabine-induced pulmonary toxicity]. Rev Mal Respir 2002 0.75
39 Evaluation of long-term results of a modified VAB-6 chemotherapy regimen in a cohort of good-risk metastatic non seminomatous germ-cell tumors. Bull Cancer 1997 0.75
40 [Paraneoplastic myasthenic syndrome]. Rev Neurol (Paris) 1993 0.75
41 [Acute hepatitis caused by erythromycin propionate]. Gastroenterol Clin Biol 1982 0.75
42 [Treatment of hepatic metastases with unknown primary cancer]. Ann Gastroenterol Hepatol (Paris) 1985 0.75
43 [Treatment aimed at a cure of a metastasized bladder cancer]. J Urol (Paris) 1985 0.75
44 [Gastric angiodysplasias and Rendu-Osler's disease]. Gastroenterol Clin Biol 1983 0.75
45 [Chemosensitive metastatic cancer cured by surgery of the residual lesions]. Chirurgie 1985 0.75
46 Evaluation of estramustine phosphate combined with weekly doxorubicin in patients with androgen-independent prostate cancer. Am J Clin Oncol 1998 0.75
47 [Primary lymphomas of the digestive tract. Therapeutic results of a series of 35 cases]. Gastroenterol Clin Biol 1984 0.75
48 [The PABA test in chronic pancreatitis: value of plasma para-amino benzoic acid determinations (author's transl)]. Nouv Presse Med 1981 0.75
49 [Primary retroperitoneal malignant germinal tumors in man]. J Urol (Paris) 1983 0.75
50 [Achalasia of neoplastic origin]. Gastroenterol Clin Biol 1984 0.75
51 [Acute alveolo-interstitial pneumopathies in HIV-negative patients treated with antineoplastic chemotherapy]. Rev Med Interne 2002 0.75
52 [Management of bladder cancer in unfit patients]. Prog Urol 2010 0.75
53 [Treatment of metastatic kidney neoplasms with a new interleukin 2 protocol: The experience of the Gustave-Roussy Institute]. Bull Cancer 1995 0.75
54 ["Superficial bladder cancers" do not exist anymore]. Prog Urol 2008 0.75
55 [Use of G-CSF in chemotherapy of urogenital cancers]. Pathol Biol (Paris) 1993 0.75
56 [Yersinia enterocolitica septicaemia associated with Yersinia intestinal lesions detected by colonoscopy (author's transl)]. Nouv Presse Med 1981 0.75
57 [Treatment of metastatic renal cancer in adults with elliptinium acetate]. Presse Med 1984 0.75
58 [Trial of premedication with lorazepam for the prevention of emetic effects of cisplatin]. Bull Cancer 1990 0.75
59 [Chemotherapy of urothelial tumors of the bladder]. Bull Cancer Radiother 1994 0.75
60 [Primary biliary cirrhosis and pulmonary arterial hypertension]. Gastroenterol Clin Biol 1981 0.75
61 [Digestive disturbances in myotonia dystrophica. A report on four cases (author's transl)]. Gastroenterol Clin Biol 1980 0.75
62 [The enterocyte phase of absorption of triglycerides]. Gastroenterol Clin Biol 1977 0.75
63 [Maternal fetal choriocarcinoma after normal delivery]. J Gynecol Obstet Biol Reprod (Paris) 1993 0.75
64 Pattern of relapse after first line treatment of advanced stage germ-cell tumors. Eur Urol 2005 0.75